Thailand Accelerates Efforts to Upgrade Clinical Research Industry, Aiming to Increase Global Market Share
Currently, the global clinical research industry is growing rapidly, yet Thailand holds only a 1.2% share of this market. This has prompted the government to accelerate improvements to its systems to enhance competitiveness against neighboring countries like Malaysia and Vietnam, which are also continuously developing in this area.
The key to this development is addressing the "six bottlenecks," or major obstacles that cause delays in research within Thailand, including complex regulatory frameworks, budget allocation, and project approval processes. If these issues can be unlocked, it will streamline operations and attract more foreign investment.
Furthermore, the government has plans to expand research areas to Ministry of Public Health hospitals nationwide to distribute opportunities for accessing new medical innovations to the broader public, rather than limiting them to large university hospitals alone.
Upgrading this industry will not only stimulate the national economy through medical investment but also serves as a crucial opportunity to modernize the quality of healthcare, enabling Thai patients to access highly effective drugs and treatments more quickly.
In summary, accelerating the development of the clinical research industry is a vital step that Thailand must take to keep pace with international standards and maintain its position as a medical leader in the ASEAN region for the long term.